172 related articles for article (PubMed ID: 9934808)
1. Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.
Abdallah HM
Int Urol Nephrol; 1998; 30(5):617-20. PubMed ID: 9934808
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
[TBL] [Abstract][Full Text] [Related]
3. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
Waldhauser M; Schramek P
J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
[TBL] [Abstract][Full Text] [Related]
4. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
Floth A; Schramek P
J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
Bechara A; Casabé A; Chéliz G; Romano S; Fredotovich N
J Urol; 1996 Mar; 155(3):913-4. PubMed ID: 8583605
[TBL] [Abstract][Full Text] [Related]
6. [3 years' experience with intracavernous auto-injection therapy].
Weiske WH
Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
[TBL] [Abstract][Full Text] [Related]
7. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Lee LM; Stevenson RW; Szasz G
J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
[TBL] [Abstract][Full Text] [Related]
9. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
[TBL] [Abstract][Full Text] [Related]
11. The value of a second injection on the pharmaco-induced erection test.
Pagani E; Puech-Leão P; Glina S; Reis JM
Int J Impot Res; 1997 Sep; 9(3):167-8. PubMed ID: 9315495
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
Seyam R; Mohamed K; Akhras AA; Rashwan H
Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
[TBL] [Abstract][Full Text] [Related]
14. New developments in self-injection therapy for erectile dysfunction.
Gingell JC
Br J Urol; 1998 Apr; 81(4):599-603. PubMed ID: 9598634
[No Abstract] [Full Text] [Related]
15. [Prostaglandin E1 in erectile dysfunction].
Porst H
Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
[TBL] [Abstract][Full Text] [Related]
16. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
Bechara A; Casabé A; Chéliz G; Romano S; Rey H; Fredotovich N
J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599
[TBL] [Abstract][Full Text] [Related]
18. An improved vasoactive drug combination for a pharmacological erection program.
Bennett AH; Carpenter AJ; Barada JH
J Urol; 1991 Dec; 146(6):1564-5. PubMed ID: 1719248
[TBL] [Abstract][Full Text] [Related]
19. Erectile dysfunction: intracavernous treatment.
Ledda A
Curr Med Res Opin; 2000; 16 Suppl 1():s59-62. PubMed ID: 11329824
[TBL] [Abstract][Full Text] [Related]
20. Experience with triple-drug therapy in a pharmacological erection program.
Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
